Enzymatic routes to site-specific protein-nucleic acid conjugates
- 1Molecular Enzymology, University of Groningen, Feringa Building, Groningen, Netherlands, 9747AG
Abstract
Nature rarely joins nucleic acids to proteins covalently, yet synthetic protein-nucleic acid conjugates enable diverse applications from nanotechnology to therapeutics, which require or benefit from defined, stable, one-to-one linkages of known geometry. Here I evaluate biochemical routes to such conjugates against four ideals: enzymatic bond formation, addressability on both partners, minimal engineering of the protein of interest, and scarless linkage to unmodified nucleic acid. With an eye on biochemical mechanisms, I cover both established tools and natural systems that might become one. The available methods fall into two broad architectures. In cis, the enzyme itself becomes part of the product, allowing native chemistry on unmodified nucleic acid but requiring a folded fusion, usually at a terminus. In trans, a separate enzyme modifies the target protein and leaves a short motif, but the burden often shifts to the nucleic acid, which must carry a reactive group. No current method satisfies all four ideals, and the trade-offs largely reflect the substrate class recognized by the bond-forming enzyme. Nucleic-acid readers offer the most direct route to scarless, fully enzymatic conjugation but their requirement for large fusions limit protein-side addressability. Small-molecule readers invert this profile, enabling compact tags and greater placement flexibility at the cost of synthetic handles and a chemical final bond. Peptide readers combine short tags with enzymatic ligation but constrain attachment geometry and linkage chemistry. Site-specific, minimally invasive, scarless, and fully biochemical ProNAc formation therefore remains a tetralemma, with enzymatic activation of nucleic acids offering a promising route toward resolving it.
Related
- Cell-resolved pharmacodynamic profiling reveals tissue- and cell-population-specific activity of antisense oligonucleotide chemical conjugates in vivo
- NuXLApp: Interactive data analysis and visualization for protein‐nucleic acid crosslinking mass spectrometry
- The MODNAP benchmark set for modeling ribose-based modified nucleic acid and nucleic acid–protein complexes: a case study with AlphaFold 3
- Modular multifunctional 5HP2O linkers for the versatile assembly of protein-oligonucleotide conjugates
- Development of oligo-thioester precursors for native chemical ligation of oligo-protein conjugates.
BibTeX
@misc{furst2026enzymatic,
title = {{Enzymatic routes to site-specific protein-nucleic acid conjugates}},
author = {Maximilian J.L.J. Fürst},
howpublished = {ChemRxiv},
year = {2026},
month = sep,
doi = {10.26434/chemrxiv.15009031/v1},
url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15009031/v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Enzymatic routes to site-specific protein-nucleic acid conjugates
AU - Maximilian J.L.J. Fürst
PY - 2026
DA - 2026/09/18
PB - ChemRxiv
DO - 10.26434/chemrxiv.15009031/v1
UR - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15009031/v1
AB - Nature rarely joins nucleic acids to proteins covalently, yet synthetic protein-nucleic acid conjugates enable diverse applications from nanotechnology to therapeutics, which require or benefit from defined, stable, one-to-one linkages of known geometry. Here I evaluate biochemical routes to such conjugates against four ideals: enzymatic bond formation, addressability on both partners, minimal engineering of the protein of interest, and scarless linkage to unmodified nucleic acid. With an eye on biochemical mechanisms, I cover both established tools and natural systems that might become one. The available methods fall into two broad architectures. In cis, the enzyme itself becomes part of the product, allowing native chemistry on unmodified nucleic acid but requiring a folded fusion, usually at a terminus. In trans, a separate enzyme modifies the target protein and leaves a short motif, but the burden often shifts to the nucleic acid, which must carry a reactive group. No current method satisfies all four ideals, and the trade-offs largely reflect the substrate class recognized by the bond-forming enzyme. Nucleic-acid readers offer the most direct route to scarless, fully enzymatic conjugation but their requirement for large fusions limit protein-side addressability. Small-molecule readers invert this profile, enabling compact tags and greater placement flexibility at the cost of synthetic handles and a chemical final bond. Peptide readers combine short tags with enzymatic ligation but constrain attachment geometry and linkage chemistry. Site-specific, minimally invasive, scarless, and fully biochemical ProNAc formation therefore remains a tetralemma, with enzymatic activation of nucleic acids offering a promising route toward resolving it.
ER -